Danaher Corporation (DHR) is currently trading at $179.14. Based on 23 Wall Street analysts, the average target price is $228.61, implying a 27.6% upside. The consensus recommendation is STRONG BUY.

DHR

Danaher Corporation

HealthcareOpinion: strong buy

Opinion Criteria: Based on the consensus of Wall Street analysts. Strong Buy (1.0-1.5), Buy (1.5-2.5), Hold (2.5-3.5), Sell (3.5-4.5), Strong Sell (4.5-5.0).

Price (USD)

$179.14

Consensus target price range

Low–high band from analyst PT changes in the last 3 months; median & sample mean vs current price

LowHigh
$95.00$236.00
Current $179.14
Median: $215.00Mean: $202.33Current: $179.14

Recent price target updates (latest 80)

  • Wells FargoJul 22, 2026

    PT action: Lowers

    $212.00 → $195.00

  • TD CowenJul 22, 2026

    PT action: Lowers

    $240.00 → $236.00

  • StifelJul 22, 2026

    PT action: Lowers

    $260.00 → $220.00

  • GuggenheimJul 22, 2026

    PT action: Lowers

    $235.00 → $200.00

  • RBC CapitalJul 22, 2026

    PT action: Raises

    $200.00 → $215.00

  • Evercore ISI GroupJul 6, 2026

    PT action: Lowers

    $232.00 → $230.00

  • Piper SandlerJun 11, 2026

    PT action: Announces

    $0.00 → $200.00

  • HSBCJun 3, 2026

    PT action: Lowers

    $270.00 → $230.00

  • CitigroupMay 27, 2026

    PT action: Lowers

    $125.00 → $95.00

  • Morgan StanleyApr 23, 2026

    PT action: Lowers

    $270.00 → $255.00

  • UBSApr 22, 2026

    PT action: Lowers

    $270.00 → $250.00

  • Wells FargoApr 22, 2026

    PT action: Lowers

    $240.00 → $212.00

  • GuggenheimApr 22, 2026

    PT action: Lowers

    $275.00 → $235.00

  • BairdApr 22, 2026

    PT action: Lowers

    $249.00 → $245.00

  • BairdApr 17, 2026

    PT action: Lowers

    $251.00 → $249.00

  • BarclaysApr 14, 2026

    PT action: Lowers

    $250.00 → $230.00

  • Goldman SachsApr 13, 2026

    PT action: Lowers

    $265.00 → $230.00

  • Evercore ISI GroupApr 6, 2026

    PT action: Lowers

    $254.00 → $225.00

  • JP MorganJan 29, 2026

    PT action: Raises

    $270.00 → $275.00

  • JefferiesJan 29, 2026

    PT action: Raises

    $255.00 → $265.00

Band uses only the revised target (Current column) from firm actions dated within the last 3 months—not the Prior price.

Avg Target

$228.61

Based on 23 analysts

Analyst Recommendations

Buy (22)Hold (4)Sell (0)

Upside

+27.61%

Market Cap

$125.93B

Financial & Investment Metrics

Next Earnings Date
Oct 20, 2026D-90
P/E Ratio (TTM)34.72
Forward P/E19.32
P/B Ratio2.39
Dividend Yield0.89%
Return on Equity (ROE)7.61%
Operating Margin17.99%
Debt to Equity50.50
Beta (Volatility)N/A
52 Week Range$160.93 - $242.80
LowCurrent: $179.14High

Latest News

Daily editorial mentioning DHR

Price target moves

Utilities and GM Drive Active Revision Cycle Across Large-Cap Names

The data as of July 23, 2026, reflects a high volume of target price adjustments, particularly within the defensive Utilities sector and among select industrials and consumer names. Analysts have been busy recalibrating expectations, creating a distinct divergence in sentiment.

Upgrades and downgrades

General Motors saw a flurry of attention, with Wells Fargo, Morgan Stanley, and TD Cowen all nudging their targets higher. Specifically, the firm moved from $60 to $61, $100 to $101, and $126 to $132, respectively. Despite these upward revisions, the consensus mean target suggests an implied upside of 19.1%, highlighting how individual analyst optimism can sometimes congregate around a specific narrative.

Elsewhere, the Utilities sector is experiencing a tug-of-war. BMO Capital initiated a string of downward revisions for several names, including XEL (95 to 92), WEC (120 to 117), SO (105 to 102), PNW (106 to 104), PCG (28 to 27), OGE (50 to 49), and ES (73 to 72). These moves contrast sharply with the same firm's upward adjustments for EVRG (88 to 92) and ETR (123 to 124). Morgan Stanley also signaled a cooling on healthcare names, lowering DHR from 212 to 195 and ZTS from 115 to 99.

Ticker Firm Dir Prior → Current
GM TD Cowen Up 126 → 132
DHR Wells Fargo Down 212 → 195
SCHW UBS Up 122 → 128
NOC TD Cowen Down 580 → 550

For those tracking the broader trend of market moves, the concentration of activity in Utilities suggests that firms are tightening their outlooks on rate-sensitive equities even as other sectors like Industrials—exemplified by MMM’s move to $218 from $190 at UBS—see continued support.

Limits of the data

These figures represent a snapshot of analyst sentiment over the last 14 days and do not account for daily volatility or broader macroeconomic shifts. While a price target revision provides a window into institutional thinking, it remains a projection. The gap between a revised target and current market pricing is often influenced by factors outside the analyst’s immediate model, such as sector rotation or liquidity events. Investors should look at these changes as individual data points rather than a collective signal of directional momentum for any single industry.

Read article

Insider Sentiment Index (Last 6 Months)

Counts and listings exclude stock awards, gifts, and option exercises—open-market purchases and sales only.

Buy vs Sell (Count)

Insider Buys: 0Insider Sells: 10

Whale Trades (C-Level Large Buys)

No major insider buying detected recently.

Recent Insider Transactions

DateNamePositionTransactionShares
5/1/2026SPOON ALAN GDirectorSale at price 174.67 per share.1,358
2/19/2026MILOSEVICH GREGORY MOfficerSale at price 208.01 per share.1,320
11/25/2025RALES MITCHELL POfficer and DirectorSale at price 230.27 - 231.19 per share.40,625
11/18/2025LIST-STOLL TERI L.DirectorSale at price 226.50 per share.3,298
11/12/2025ELLIS BRIAN WGeneral CounselSale at price 219.21 - 219.23 per share.21,776
11/12/2025RALES MITCHELL POfficer and DirectorSale at price 217.64 - 220.15 per share.437,000
11/11/2025MCGREW MATTHEWChief Financial OfficerSale at price 214.62 per share.16,172
11/10/2025COUCHARA GEORGEANN F.OfficerSale at price 210.31 - 210.44 per share.5,174
10/31/2025RALES MITCHELL POfficer and DirectorSale at price 215.67 - 217.17 per share.600,000
8/22/2025LIST-STOLL TERI L.DirectorSale at price 211.06 per share.2,778

Frequently Asked Questions

Q. What is the current target price and upside for DHR?

A. The current target price for Danaher Corporation is $228.61, which implies a 27.6% upside from the current price of $179.14. This is based on the consensus of 23 Wall Street analysts.

Q. What is the current analyst recommendation for DHR?

A. Currently, there are 5 Strong Buy, 17 Buy, 4 Hold, 0 Sell, and 0 Strong Sell ratings. The overall consensus is STRONG BUY.

Q. Are insiders buying DHR stock recently?

A. Over the past 6 months, there have been 0 insider buys and 10 insider sells. Insider selling is more prominent recently.

Other Promising Stocks in Healthcare

Data provided by Yahoo Finance. This information is for informational purposes only and does not constitute investment advice. We bear no legal responsibility for any investment decisions made based on this data.

Read full disclaimer